Choleretic effects of curcuminoids on an acute cyclosporin-induced cholestasis in the rat

被引:23
作者
Deters, M
Siegers, C
Muhl, P
Hänsel, W
机构
[1] Inst Expt & Clin Pharmacol & Toxicol, D-18055 Rostock, Germany
[2] Univ Kiel, Inst Pharmaceut, Kiel, Germany
[3] Univ Lubeck, Inst Toxicol, D-2400 Lubeck, Germany
关键词
curcumin; bisdemethoxycurcumin; cyclosporin; cholestasis; Curcuma spec; Zingiberaceae;
D O I
10.1055/s-1999-14033
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Former studies have shown that curcumin, which can be extracted from different Curcuma species, is able to stimulate bile flow in rats, whereas bisdemethoxycurcumin, which is mainly found in rhizomes of Curcumca longo, is believed to inhibit bile flow To reevaluate this observation we investigated the influence of both curcuminoids on bile flow, bile acid concentration and excretion over a time period of 180 min in the bile fistula model in rats. Furthermore, we tested the ability of both curcuminoids to reduce cyclosporin-induced cholestasis. 30 min after intravenous injection of 25 mg/kg of curcumin and bisdemethoxycurcumin bile flow was enhanced from 500 mu l/kg/15 min (100 %) to 180 % and to 220 %, respectively. The choleretic effect of bisdemethoxycurcumin lasted longer than that of curcumin. Following intravenous injection of 30 mg/kg of cyclosporin, which reduced bile flow, bile acid concentration (15 mmol/l) and excretion (12.5 mu mol/kg/15 min) to 40 % of the initial value, administration of curcumin and bisdemethoxycurcumin transiently increased bile flow to 100% and to 125% of the starting value, respectively. However, only bisdemethoxycurcumin statistically significantly attenuated cyclosporin-induced reduction of bile acid excretion. We conclude that: the beneficial properties of curcuminoids for the therapy of cyclosporin-induced cholestasis still remain to be proven.
引用
收藏
页码:610 / 613
页数:4
相关论文
共 21 条
[1]  
BAUER J, 1996, THESIS U KIEL GERMAN
[2]  
BHAT BG, 1984, J FOOD SCI TECH MYS, V21, P225
[3]  
*DTSCH ARZN, 1986, MON CURC C, V280, P1
[4]  
*DTSCH ARZN, 1991, MON JAV GELBW, P1
[5]  
HANSEL WZ, 1997, PHYTOTHER, V18, P297
[6]  
JENTZSCH K, 1959, PHARM ACTA HELV, V4, P181
[7]  
KAHAN BD, 1989, NEW ENGL J MED, V321, P1725
[8]  
LETHAI B, 1988, TRANSPLANTATION, V46, P510
[9]   HEPATOBILIARY AND PANCREATIC COMPLICATIONS OF CYCLOSPORINE THERAPY IN 466 RENAL-TRANSPLANT RECIPIENTS [J].
LORBER, MI ;
VANBUREN, CT ;
FLECHNER, SM ;
WILLIAMS, C ;
KAHAN, BD .
TRANSPLANTATION, 1987, 43 (01) :35-40
[10]  
MOSELEY RH, 1990, J PHARMACOL EXP THER, V253, P974